POTENCY OF SOME GENERIC AND ETHICAL ANTIBIOTICS BEING SOLD IN JABALPUR

Authors

  • Harleen Kaur Lamba*,Sapna Rai, Sanchali Nidhi Narula Department of Microbiology Mata Gujri Mahila Mahavidyalaya Jabalpur

Keywords:

Generic antibiotics, Ethical antibiotics, minimum inhibitory concentration, bacterial infection, potency.

Abstract

The compound either naturally occurring or synthesized in laboratory which kills the bacteria in a minimum dose were called as ‘antibiotics’. Antibiotics today are the main line of treatments for diseases caused by bacterial infection including typhoid fever, tuberculosis etc. The drug market in India and abroad contains two parallel kinds of drugs including antibiotics, ethical antibiotics and generic antibiotics. Principally both the drugs should be similar in their content and active ingredients. The present work is aimed at comparing generic antibiotics with their ethical counterpart (as per the test prescribed by Indian Pharmacoepia 2007). The main objective of the study was to clarify the concept if generic antibiotics have same potency as of their ethical counterpart. The different test bacteria were used against different antibiotics and the potency is calculated as minimum inhibitory concentration (MIC). The result showed that the ethical drugs always produced bigger zones as compared to their generic counterparts. The results clearly indicated that the generic antibiotics are not passed through stringent quality control test and hence are largely unsafe for the treatment of bacterial infection.

References

•Approval of Generic Drugs.http://www.fda.gov/downloads /ucm127615.pdf

•Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496.

•FDA basics -Drugs.http://www.fda.gov/AboutFDA/Transparency/Basics/ucm192696.htm

•Food & Drug Administration, Generic Drugs: Questions and Answers. Food and Drug Administration. January 12, 2010.

http://www.encyclopedia.com/topic/antibiotic.aspx

•Indian Pharmacoepia ;2007: general notices; monographs; 6-10

•Karolina Andersson, Christian Sonesson, Max Petzold, Anders Carlsten and Knut Lönnroth 2004. What are the obstacles to generic substitution? An assessment of the behaviour of prescribers,patients and pharmacies during the first year of generic substitution in Sweden. Pharmacoepidemiology and Drug Safety , Vol 14 Issue 5

•P.-L. Toutai and A. Bousquet-Melou. 2013. The consequences of generic marketing on antibiotic consumption and the spread of microbial resistance: the need for new antibiotics Journal of Veterinary Pharmacology and Therapeutics Vol 36 Issue 5 420–424

•Pharmacoepidemiology and Drug SafetyVolume 14, Issue 5, pages 341–348, May 2005

• Understanding Generic Drugs.http://www.fda.gov/Drugs/ResourcesForYou/Consumers/under standingGenericDrugs/default.htm

•Yutaka Inoue, , Kayoko Furuya , Miruto Matumoto , Isamu Murata ,Masayuki Kimura , Ikuo Kanamoto.2012. A comparison of the physicochemical properties and a sensory test of Acyclovir creams.Volume 436, Issues 1–2, 15 pp 265–271

Downloads

Published

2015-08-31

Issue

Section

Articles